UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported):
| (Exact name of registrant as specified in its charter) |
| (State
or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
|
|
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including
area code: (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 1.01. | Entry into a Material Definitive Agreement. |
Share Exchange Agreement. On November 12, 2026 , GridAI Technologies Corp. (the “Company”) entered into a Share Exchange Agreement (as amended by the Addendum (as defined below), the “Exchange Agreement”) by and among the Company, Pronghorn Resources, LLC, a Delaware limited liability company (“Pronghorn”), the members of Pronghorn identified therein (collectively, the “Sellers”), and Nicholas D'Onofrio, as representative of the Sellers. Pursuant to the Exchange Agreement, the Sellers will transfer to the Company all of the issued and outstanding membership units of Pronghorn (the “Units”) in exchange for an aggregate of (i) 1,247,887 shares of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), which, together with the 794,110 shares of Common Stock issuable to Sigma9 (as defined below), represent 19.99% of the shares of Common Stock outstanding prior to the closing, and (ii) up to 129,504.23 shares of the Company’s newly designated Series I Convertible Preferred Stock, par value $0.0001 per share (the “Series I Preferred Stock”), including the Escrow Shares and the Milestone Shares (each as defined below), initially convertible into an aggregate of 64,752,113 shares of Common Stock, for total consideration representing 66,000,000 common-equivalent shares (the “Share Exchange”). Upon the closing of the Share Exchange (the date of such closing, the “Closing Date”), Pronghorn will become a wholly owned subsidiary of the Company. Concurrently with the execution of the Exchange Agreement, the parties entered into an Addendum dated as of the same date (the “Addendum”), that requires Pronghorn to deliver a final list of the Sellers, and any required FIRPTA documentation, within 10 days. The closing of the Share Exchange is only conditioned upon Pronghorn delivering the final list of the Sellers and compliance with FIRPTA. The closing is expected to occur no later than November 23, 2026.
Each share of Series I Preferred Stock has an original issue price and liquidation value of $1,000 and is convertible into shares of Common Stock at an initial conversion price of $2.00 per share (an initial conversion ratio of 500 shares of Common Stock per share of Series I Preferred Stock). The Series I Preferred Stock may not be converted until (i) the Company’s stockholders approve the conversion in accordance with Nasdaq listing rules (the “Stockholder Approval”) and (ii) Nasdaq has approved the listing of the shares of Common Stock issuable upon conversion. Conversion is further subject to a beneficial ownership limitation initially set at 9.99%, which a holder may adjust to between 4.99% and 19.99%; any increase above the then-applicable limitation is not effective until the 61st day after notice to the Company, and the limitation may not be waived. Effective automatically upon the approval, if and when received, of the Company’s stockholders for, the conversion of the outstanding shares of the Company’s Series H Convertible Preferred Stock and receipt of any required Nasdaq approval (the “Series H Conversion”), each outstanding share of Series I Preferred Stock will be adjusted to equal 2.74724 shares of Series I Preferred Stock assuming the full conversion of the Series H Convertible Preferred Stock into 38,801,546 shares of Common Stock, whether the Series H Conversion occurs before or after issuance,. Upon such adjustment, the Series I Preferred Stock issued to the Sellers would represent approximately 355,779.20 shares of Series I Preferred Stock, convertible into approximately 177,889,600 shares of Common Stock. In the event that the Series H Convertible Preferred Stock becomes convertible or exchangeable into a different number, the adjustment factor and the number of shares of Series I Preferred Stock and shares of Common Stock issuable upon conversion thereof shall be adjusted accordingly. The Series I Preferred Stock has no voting rights except as required by the Delaware General Corporation Law until receipt of the Stockholder Approval, is not entitled to dividends except as required by law, is perpetual and not redeemable, and ranks senior to junior securities, on parity with the Company’s previously designated series of preferred stock and junior to any senior securities upon liquidation. Until the Stockholder Approval has been obtained and the shares of Common Stock issuable upon conversion of the Sellers’ Series I Preferred Stock (the “Exchange Conversion Shares”) have been registered,for resale under an effective registration statement, the Company may not, without the consent of the holders of a majority of the outstanding Series I Preferred Stock, among other things, incur indebtedness for borrowed money (other than Pronghorn working capital facilities in the ordinary course), adversely amend the rights of the Series I Preferred Stock, create senior equity securities, pay dividends on Common Stock or junior securities, make capital expenditures in excess of $500,000 outside the ordinary course without Board approval, or divert the Pronghorn working capital reserve. Of the shares of Series I Preferred Stock issued to the Sellers, 13,200 shares (the “Escrow Shares”) are being held by the Company following the closing as security for the Sellers’ indemnification obligations under the Exchange Agreement. Following the expiration of the initial 18-month survival period, up to 13,200 Escrow Shares will be released to the Sellers if pending indemnification claims do not exceed the value of the remaining Escrow Shares, and the remaining Escrow Shares will be released, less shares retained for unresolved claims, following the expiration of the remaining applicable indemnification period. In addition, 6,600 shares of Series I Preferred Stock (the “Milestone Shares”) are being held by the Company and will be issuable to the Sellers only upon written notice from the Sellers’ representative that Pronghorn has completed at least 120 qualifying well workovers during the period from November 1, 2026 through April 30, 2027.
The Exchange Agreement contains customary representations, warranties, covenants and indemnification provisions. Pursuant to the Exchange Agreement, the Company has agreed, among other things, to (i) use its reasonable best efforts to hold a meeting of its stockholders to obtain the Stockholder Approval, together with approval of an increase in the number of authorized shares of Common Stock to 500,000,000, within 90 days following the Closing Date, subject to extension to obtain the audited financial statements of Pronghorn, but in no event later than 180 days following the Closing Date; and (ii) maintain a working capital reserve of $10,000,000, less the principal amount funded under the Note (as defined below), from the net proceeds of the Company’s financing as a working capital reserve to be used solely for the business of Pronghorn. In addition, the Sellers have the right to designate one director to the Board of Directors of the Company (the “Board”) at the closing, and one additional director following receipt of the Stockholder Approval, in each case subject to the Company’s consent (not to be unreasonably withheld) and Nasdaq independence and qualification requirements. For so long as the Sellers collectively hold at least 10% of the outstanding Common Stock (on an as-converted basis), the Sellers will have the continuing right to designate two directors for nomination to the Board at each annual meeting, and for so long as the Sellers collectively hold at least 30% of the outstanding Common Stock (on an as-converted basis), the Company may not increase the size of the Board above five members without the consent of the holders of a majority of the Sellers’ Series I Preferred Stock. Prior to the appointment of the second Seller designee, the Sellers are also entitled to appoint one non-voting Board observer.
Closing Deliverables. Pursuant to the Exchange Agreement, at the closing of the Share Exchange, (i) the Company and the Sellers will enter into a registration rights agreement providing for, among other things, the registration for resale of the shares of Common Stock issued to the Sellers and issuable upon conversion of their Series I Preferred Stock, with liquidated damages payable if a registration statement is not effective within 180 days following the filing deadline; (ii) each Seller will enter into a voting agreement agreeing to vote its share in favor of the Company’s slate of director nominees, subject to the Company’s compliance with the Sellers’ board designation rights; (iii) each Seller will enter into a lock-up agreement restricting transfers of the shares received in the Share Exchange and the shares issuable upon conversion thereof for 30 months following the Closing Date; and (iv) the Company will amend the $5,000,000 Amended and Restated Secured Convertible Note dated October 21, 2026 issued by Pronghorn to the Company (the “Note”) to delete the Company’s right to convert the Note upon a default thereunder. The Company expects to describe these agreements and file them as exhibits to the Current Report on Form 8-K reporting the closing of the Share Exchange.
Stockholder Support Agreements. In connection with the Exchange Agreement, certain of the Company’s officers, directors and stockholders entered into Stockholder Support Agreements with the Company (the “PubCo Support Agreements”), pursuant to which each such stockholder agreed, until the earliest of the receipt of the Stockholder Approval, the termination of the Exchange Agreement prior to closing and the shareholder meeting deadline under the Exchange Agreement, to vote all of its shares of Common Stock in favor of the matters submitted for the Stockholder Approval (including the increase in authorized shares of Common Stock and the conversion of the Series I Preferred Stock) and against any competing proposal, and granted the Company an irrevocable proxy to vote such shares accordingly. Each stockholder also agreed not to transfer all of its shares, subject to customary exceptions, and not to solicit alternative acquisition proposals, and waived appraisal rights. Following the closing, the Sellers’ representative is a third-party beneficiary entitled to enforce the PubCo Support Agreements.
Sigma9 Assignment. Concurrently with the closing of the Share Exchange, the Company expects to enter into an Assignment and Assumption Agreement (the “Assignment Agreement”) with SIGMA9 Capital Ltd., a Cayman Islands exempted company (“Sigma9”), acknowledged by 1st American Nuclear Co., a Delaware corporation (“FANCO”), pursuant to which Sigma9 will assign to the Company its rights and obligations under an Amended and Restated Joint Venture Agreement with FANCO relating to the development of small modular reactor power generation facilities in Wyoming, in exchange for 794,110 shares of Common Stock and 82,411.78 shares of Series I Preferred Stock. The Company expects to describe the Assignment Agreement and file it as an exhibit to the Current Report on Form 8-K reporting the closing of the Share Exchange.
The foregoing descriptions of the Exchange Agreement and the PubCo Support Agreements do not purport to be complete and are qualified in their entirety by reference to the full text of such agreements, copies or forms of which are filed as Exhibits 2.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The representations, warranties and covenants contained in such agreements were made solely for the benefit of the parties thereto, may be subject to limitations agreed upon by the contracting parties and should not be relied upon by investors as characterizations of the actual state of facts or condition of the Company, Pronghorn or any other party.
| Item 2.01. | Completion of Acquisition or Disposition of Assets. |
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. Pursuant to the Addendum, all conditions to the closing of the Share Exchange other than delivery of the Seller Documentation have been satisfied, and upon delivery of the Seller Documentation, which is required no later than November 22, 2026, the Share Exchange will be deemed consummated, the Company will acquire all of the Units and Pronghorn will become a wholly owned subsidiary of the Company. Concurrently with the closing of the Share Exchange, the Company will acquire Sigma9’s rights under the JV Agreement pursuant to the Assignment Agreement. The Company will file an amendment to this Current Report on Form 8-K to report the consummation of the Share Exchange.
Following the closing, and after giving effect to the issuance of the shares of Common Stock and Series I Preferred Stock described above (and before giving effect to any share withheld pursuant to the FIRPTA provisions of the Addendum), the Company will have 12,257,087 shares of Common Stock issued and outstanding and an aggregate of 211,916.01 shares of Series I Preferred Stock outstanding (including the Escrow Shares and the Milestone Shares). On a fully diluted, as-converted basis (excluding the Series H Preferred Stock, outstanding options and warrants, and without giving effect to beneficial ownership limitations), the Sellers and Sigma9 would hold approximately 55.8% and 35.5%, respectively, of the Company’s fully diluted shares of Common Stock.
| Item 3.02. | Unregistered Sales of Equity Securities. |
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. The shares of Common Stock and Series I Preferred Stock to be issued to the Sellers (and the shares of Common Stock issuable upon conversion thereof) will be issued in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Regulation D promulgated thereunder. Each Seller represented that it is an “accredited investor” as defined in Rule 501(a) of Regulation D or a “qualified institutional buyer” as defined in Rule 144A.
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Effective as of the closing, the Sellers will be entitled to designate one director to the Board. The Sellers will be entitled to designate one additional director to the Board following receipt of the Stockholder Approval. Insert biographical information, committee appointments, compensatory arrangements and Item 404(a) disclosure, or delete if not applicable.
| Item 5.03. | Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. |
On November 12, 2026, the Company filed with the Secretary of State of the State of Delaware a Certificate of Designation of Preferences, Rights and Limitations of Series I Convertible Preferred Stock (the “Series I Certificate of Designation”), designating 585,000 shares of Series I Preferred Stock for issuance under both the Exchange Agreement and the Assignment Agreement, of which no more than 211,916.01 shares may be issued unless the Series H Conversion has been approved by the Company’s stockholders, and which will be adjusted to approximately 582,184.15 shares upon the Series H Conversion. The information set forth in Item 1.01 regarding the terms of the Series I Preferred Stock is incorporated herein by reference. The foregoing description is qualified in its entirety by reference to the Series I Certificate of Designation, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
| Item 7.01. | Regulation FD Disclosure. |
On November 12, 2026, the Company issued a press release announcing the entry into the Exchange Agreement and the transactions contemplated thereby, including the Assignment Agreement, a copy of which is furnished as Exhibit 99.1. The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.
* Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GridAI Technologies Corp. | ||
| November 17, 2026 | By: | /s/ Jason D. Sawyer |
| Name: | Jason D. Sawyer | |
| Title: | Interim Chief Executive Officer | |